- Home
- XYF vs LUCD Comparison
XYF vs LUCD Comparison
Compare XYF & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XYF | LUCD |
|---|---|---|
| Founded | 2014 | 2018 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 224.3M | 190.8M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | XYF | LUCD |
|---|---|---|
| Price | $4.56 | $1.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.13 |
| AVG Volume (30 Days) | 206.6K | ★ 574.9K |
| Earning Date | 05-18-2026 | 05-13-2026 |
| Dividend Yield | ★ 12.26% | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,346,000.00 |
| Revenue This Year | N/A | $126.14 |
| Revenue Next Year | N/A | $138.77 |
| P/E Ratio | $0.90 | ★ N/A |
| Revenue Growth | N/A | ★ 79.00 |
| 52 Week Low | $3.30 | $0.95 |
| 52 Week High | $20.36 | $1.70 |
Technical Indicators
Market Signals| Indicator | XYF | LUCD |
|---|---|---|
| Relative Strength Index (RSI) | 52.59 | 68.58 |
| Support Level | $3.30 | $1.01 |
| Resistance Level | $5.07 | $1.52 |
| Average True Range (ATR) | 0.34 | 0.07 |
| MACD | 0.08 | 0.03 |
| Stochastic Oscillator | 88.97 | 98.41 |
Price Performance
Historical ComparisonAbout XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.